跳至主要内容
临床试验/CTRI/2020/12/029984
CTRI/2020/12/029984招募中不适用

A STUDY OF COAGULATION MARKERS AND THEIR CORRELATION WITH CLINICAL SEVERITY IN COVID 19 ILNESS

Smt NHL Municipal Medical College1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年12月28日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
1
主要终点
In-hospital stay (Duration and Type of stay: ICU or Ward)

研究概览

简要总结

Study Design:

Cross sectional, prospective, observational study

 Study Duration:

24 months after IRB/CTRI approval

Hypothesis:

  • In patients with COVID-19, there is a  progression from adaptive hemostasis to pathologically induced Disseminated Intravascular Coagulopathy (DIC) to multi organ failure.

 

  • Hence, coagulation profile in Covid 19 disease could be a significant marker to predict the clinical severity of disease and hence the overall outcome of patients from the disease.

 Aims and Objectives:

  • Studying the coagulation markers and their progression in COVID-19 .

  • Correlation of coagulation markers with the clinical severity of COVID-19

  • Outcome of patients with elevated coagulation markers in terms of:

  • In-hospital stay (Duration and Type of stay: ICU or Ward)

  • Morbidity (PE, DVT,Stroke,etc)

  • Mortality

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Inpatients in General Medicine with a established diagnosis of COVID 19 infection( Laboratory confirmed ) Patients with abnormal coagulation markers Patients of age >18 years.

排除标准

  • Patients with proven others causes of coagulopathy.
  • VTE, DVT, Recent Surgery/Trauma, Pregnancy, Cancer Patients already on anticoagulant therapy.

结局指标

主要结局

In-hospital stay (Duration and Type of stay: ICU or Ward)

时间窗: At Baseline, Every 3rd Day till Discharge/Death

次要结局

  • Morbidity (PE, DVT,Stroke,etc)(Mortality)

研究者

发起方
Smt NHL Municipal Medical College
申办方类型
Other [Municipal Medical College]

研究点 (1)

Loading locations...

相似试验